rs747799506
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BA1BP4BS2_SupportingBP5
This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Val966Ile variant in CDKL5 is 0.03% in South Asian sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Val966Ile variant is observed in at least 1 unaffected individual (internal database) (BS2_supporting). Computational analysis prediction tools suggest that the p.Val966Ile variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Val966Ile variant is found in a patient with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Val966Ile variant in CDKL5 is classified as benign based on the ACMG/AMP criteria applied (BA1, BS2_supporting, BP4, BP5). LINK:https://erepo.genome.network/evrepo/ui/classification/CA209185/MONDO:0100039/016
Frequency
Consequence
ENST00000379989.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.185-3176C>T | intron_variant | ENST00000379984.4 | NP_000321.1 | |||
CDKL5 | NM_001037343.2 | c.2896G>A | p.Val966Ile | missense_variant | 21/22 | NP_001032420.1 | ||
CDKL5 | NM_003159.3 | c.2896G>A | p.Val966Ile | missense_variant | 20/21 | NP_003150.1 | ||
RS1 | XM_047442337.1 | c.-125C>T | 5_prime_UTR_variant | 1/4 | XP_047298293.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RS1 | ENST00000379984.4 | c.185-3176C>T | intron_variant | 1 | NM_000330.4 | ENSP00000369320 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112374Hom.: 0 Cov.: 24 AF XY: 0.0000290 AC XY: 1AN XY: 34520
GnomAD3 exomes AF: 0.0000327 AC: 6AN: 183481Hom.: 0 AF XY: 0.0000589 AC XY: 4AN XY: 67911
GnomAD4 exome AF: 0.0000464 AC: 51AN: 1098012Hom.: 0 Cov.: 30 AF XY: 0.0000605 AC XY: 22AN XY: 363382
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112374Hom.: 0 Cov.: 24 AF XY: 0.0000290 AC XY: 1AN XY: 34520
ClinVar
Submissions by phenotype
CDKL5 disorder Benign:2
Benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Mar 26, 2021 | The allele frequency of the p.Val966Ile variant in CDKL5 is 0.03% in South Asian sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Val966Ile variant is observed in at least 1 unaffected individual (internal database) (BS2_supporting). Computational analysis prediction tools suggest that the p.Val966Ile variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Val966Ile variant is found in a patient with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Val966Ile variant in CDKL5 is classified as benign based on the ACMG/AMP criteria applied (BA1, BS2_supporting, BP4, BP5). - |
Benign, criteria provided, single submitter | curation | Centre for Population Genomics, CPG | Jul 12, 2024 | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 04, 2015 | - - |
Developmental and epileptic encephalopathy, 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 24, 2020 | This variant is associated with the following publications: (PMID: 23756444, 23242510) - |
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 11, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at